Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 88 of 1714:
78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type I, beta DIPHENHYDRAMINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DIPHENHYDRAMINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 1 ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 2 ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma PRAZOSIN Sodium Channel, Site 2 58% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 PHENELZINE Cyclooxygenase COX-2 58% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) PHENELZINE Cyclooxygenase COX-2 58% NoneNone NoneNone View
adrenergic receptor, alpha 2a LOMUSTINE Imidazoline I2, Central 58% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) LOMUSTINE Imidazoline I2, Central 58% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 GW-1929 Dopamine Transporter 58% 13.551uM 10.767uM View
adrenergic receptor, alpha 1a ECONAZOLE Adrenergic alpha1A 58% 21.16uM 8.565uM View
monoamine oxidase A METHOXSALEN Monoamine Oxidase MAOA 58% NoneNone NoneNone View
monoamine oxidase A METHOXSALEN Monoamine Oxidase MAOA 58% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 DEXIBUPROFEN Cyclooxygenase COX-2 58% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) DEXIBUPROFEN Cyclooxygenase COX-2 58% NoneNone NoneNone View
adrenergic receptor, alpha 2a DEXCHLORPHENIRAMINE Imidazoline I2, Central 58% 15.214uM 10.142uM View
adrenergic receptor, alpha 2c (Non-specific probe) DEXCHLORPHENIRAMINE Imidazoline I2, Central 58% 15.214uM 10.142uM View
dopamine receptor D3 CIGLITAZONE Dopamine D3 58% 26.704uM 9.069uM View
calcium channel, voltage-dependent, gamma subunit 8 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit MEVASTATIN Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H, member 8 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 FLUOXETINE Potassium Channel HERG 58% 12.2864uM 10.066uM View
melanocortin 4 receptor PERHEXILINE Melanocortin MC4 58% NoneNone NoneNone View
acetylcholinesterase (YT blood group) BETA-NAPHTHOFLAVONE Acetylcholinesterase 58% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase BETA-NAPHTHOFLAVONE Acetylcholinesterase 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DIPHENHYDRAMINE Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DISULFIRAM Adrenergic, Norepinephrine Transporter 56% 70.37uM 69.812uM View
arachidonate 15-lipoxygenase, second type DISULFIRAM Lipoxygenase 15-LO 56% 16.066uM NoneNone View
arachidonate 15-lipoxygenase DISULFIRAM Lipoxygenase 15-LO 56% 16.066uM NoneNone View
arachidonate 15-lipoxygenase DISULFIRAM Lipoxygenase 15-LO 56% 16.066uM NoneNone View
sodium channel, voltage-gated, type III, alpha MEGESTROL ACETATE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta MEGESTROL ACETATE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 MEGESTROL ACETATE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta MEGESTROL ACETATE Sodium Channel, Site 2 56% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha MEGESTROL ACETATE Sodium Channel, Site 2 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
A3 adenosine receptor SULINDAC Adenosine A3 9% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LABETALOL Calcium Channel Type L, Benzothiazepine 56% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha ANTIMYCIN A Sodium Channel, Site 2 55% NoneNone NoneNone View
opioid receptor, kappa 1 PHENTOLAMINE Opiate kappa 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 1 NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel associated protein 2 NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta NOSCAPINE Sodium Channel, Site 2 55% NoneNone NoneNone View
A3 adenosine receptor ASTEMIZOLE Adenosine A3 55% 29.12uM 16.461uM View
matrix metalloproteinase 1 (interstitial collagenase) SULFASALAZINE Protease, Matrix Metalloprotease-1 (MMP-1) 55% 23.549uM NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DOXAZOSIN Calcium Channel Type L, Phenylalkylamine 55% NoneNone NoneNone View
acetylcholinesterase BETA-NAPHTHOFLAVONE Acetylcholinesterase 58% NoneNone NoneNone View
tachykinin receptor 2 HYDROXYPROGESTERONE Tachykinin NK2 58% NoneNone NoneNone View
Sigma-2 Receptor VALETHAMATE BROMIDE Sigma2 58% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 PROPAFENONE Serotonin Transporter 58% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 4-NONYLPHENOL Serotonin 5-HT6 58% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 MONTELUKAST Muscarinic M5 58% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 METHAPYRILENE Muscarinic M4 58% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 SALINOMYCIN CYP450-3A4 Inhibition 58% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) PAPAVERINE CYP450-2C9 Inhibition 58% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 PAPAVERINE CYP450-2C9 Inhibition 58% NoneNone NoneNone View
A3 adenosine receptor TERFENADINE Adenosine A3 58% NoneNone NoneNone View
opioid receptor, delta 1 3,3',4',5-TETRACHLOROSALICYLANILIDE Opiate delta 58% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) AMITRAZ Adrenergic alpha1D 58% NoneNone NoneNone View
tachykinin receptor 2 CLOSANTEL Tachykinin NK2 58% NoneNone NoneNone View
histamine receptor H 1 DIPHENIDOL Histamine H1, Central 58% NoneNone NoneNone View
Sigma-2 Receptor DIPHENIDOL Sigma2 58% NoneNone NoneNone View
mu-opioid receptor MOR DOBUTAMINE Opiate mu 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit DOBUTAMINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View